Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03779009 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Minimally INvasive Colon Cancer Surgery Through IMmunomics and Optical Mapping of the Sentinel Lymph Node.

Study acronym: MINIMAL
StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 19, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Lead sponsor: University Ghent to University Hospital, Ghent
    • Site contact updated
    • Collaborators: 2 to 1
    v8
  3. Re-verified, no change to tracked fieldsv7
  4. Primary completion date: Dec 31, 2023 to Dec 31, 2025
    • Study completion date: Dec 31, 2024 to Dec 31, 2025
    v6
  5. Primary completion date: Dec 31, 2022 to Dec 31, 2023
    • Study completion date: Dec 31, 2022 to Dec 31, 2024
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary completion date: Aug 31, 2022 to Dec 31, 2022v4
  2. Primary completion date: Dec 31, 2020 to Aug 31, 2022
    • Study completion date: Dec 31, 2021 to Dec 31, 2022
    v3
  3. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The project investigates the feasibility of laparoscopic fluorescent imaging for the intraoperative detection of the sentinel lymph node (SLN) in colon cancer patients. In addition, the topology of immunological and microenvironmental changes in normal and invaded lymph nodes (LN's) will be correlated to the LN location (anatomical mapping).
Trial Details
NCT Number NCT03779009
Lead Sponsor University Hospital, Ghent
Collaborators: Kom Op Tegen Kanker
Conditions
(from sponsor)		 Colon Cancer, Sentinel Lymph Node
Related terms Colonic Neoplasms
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov